Where does Milad Alucozai work?

Milad Alucozai is Co-Founder & General Partner at Pamir Ventures and Co-Founder at Revalia Bio, Inc..

What check size does Milad Alucozai write?

Milad Alucozai typically writes checks of $500K.

What boards does Milad Alucozai sit on?

Milad Alucozai holds tracked board seats at Revalia Bio, Inc..

Where did Milad Alucozai go to school?

Milad Alucozai studied at Harvard University (Visiting Fellow/Scholar, Wyss Institute for Biologically Inspired Engineering); Purdue University (RCHE/Bindley Entrepreneurship Fellow, Healthcare Engineering); The Johns Hopkins University School of Medicine (Gordon and Marilyn Macklin Fellow).

Milad Alucozai

Investor

Co-Founder & General Partner at Pamir Ventures · External Advisor at Amgen Ventures · Co-Founder at Revalia Bio, Inc.

San Francisco, California, United States

Writes $500K checks

Find your path to Milad

3,841 people in our graph share verified history with Milad — schools, employers, funds. One of them is your warm intro.

Harley FinkelsteinunlockedMilad: together at C100

Milad: together at C100

×10Milad: together at Harvard University

About

Milad Alucozai, a former bench scientist turned founder (Mekonos, Corstem, Revalia Bio), brings deep technical and operator expertise, mentors at Wyss Institute, and co‑launched Code to Cure on AI–biology convergence.

Invests in

AgTechAI & Machine LearningBiotechClimate TechDeep TechFoodTechHardware

Co-Founder at Revalia Bio, Inc.

Intro paths

→

In turn, Milad can intro founders to Revalia Bio, Inc.'s investors below.

Revalia Bio, Inc.'s investors · 6

America's Frontier FundArlington · $500K – $10M checks · since 2024 BoxOne VenturesMontréal · $500K checks · since 2024 Connecticut InnovationsNew Haven · $500K – $2M checks · since 2024 DniproPalo Alto · since 2024 Entrepreneur FirstBengaluru · $1M – $7M checks · since 2024 Sierra VenturesSan Mateo · $10M checks · since 2024

Co-founders at Revalia Bio, Inc.

Greg TietjenCo-Founder & Chief Executive Officer

Jenna DiRitoCo-Founder

Kourosh Saeb-ParsyCo-Founder

Helen HughesCo-Founder & Chief People Officer

Peter BuniakCo-Founder & Advisor

Jenna DiRito, PhDFounder

Experience

Pamir VenturesCo-Founder & General Partnercurrent2025 — presentSan Francisco Bay Area
Critical Path Institute (C-Path)Board Membercurrent2026 — present
AmgenExternal Advisorcurrent2026 — present
Revalia BioCo-Foundercurrent2022 — present
Wyss Institute at Harvard UniversityAdvisory Committeecurrent2024 — presentBoston, MA
Creative Destruction LabMentor - Recipient of Mentor of the Year Awardcurrent2019 — present
Talus BioBoard Membercurrent2023 — presentSeattle, Washington, United States
Digitalis CommonsExpert in Residence2024 — 2026Washington, DC
Seqera LabsFirst investor and Board Member2020 — 2026
C100Inducted Member2024 — 2026San Francisco Bay Area
BoxOne VenturesHead of Life Sciences & Deep Tech2018 — 2024
Entrepreneur FirstVenture Partner2020 — 2023San Francisco / Toronto / UK
Harvard UniversityExecutive Expert & Mentor at Harvard Innovation Labs2020 — 2023
bit.bioInvestor & Strategic Business Advisor2022 — 2023Greater London
Mekonos Inc.Board Member2020 — 2023San Francisco Bay Area
Mekonos Inc.Early Investor & Chief Business Officer2018 — 2020San Francisco Bay Area
AstraZenecaExternal Advisor2020 — 2022
AbsciBusiness Development Advisor (NASDAQ: ABSI)2020 — 2021
Purdue UniversityVisiting Scholar in Healthcare Engineering at the Regenstrief Center2018 — 2020
Numerate, Inc.Business Development Team (acquired by Valo Health)2016 — 2019San Francisco Bay Area
AccentureGlobal Portfolio & Delivery Lead2016 — 2018London Area, United Kingdom
Discovery Park at Purdue UniversityScientist at Interfacial Multiphysics Lab2013 — 2015Interfacial Multiphysics Lab
Discovery Park at Purdue UniversityTech Analyst Emerging Innovations Venture Fund2013
Discovery Park at Purdue UniversityAssistant Scientist at Birck Nanotechnology Center2012 — 2013https://www.purdue.edu/discoverypark/birck/
CellafloraFounding Team - Business Development (acquired by OnBoard)2010 — 2014www.cellaflora.com
Purdue University Translational Neuroscience LabAssistant Scientist2006 — 2010

Skills & more

Corporate Governance1Strategic Partnerships2Due Diligence95Biotechnology98Research99Entrepreneurship99Nonprofits97Venture Capital26Data Analysis25Public Policy23Grant Writing19Policy Analysis17

+12 more

Strategic PlanningStart-upsAdventure TravelNanotechnologyNanomaterialsPublic SpeakingLeadershipFundraisingMentoringManagementinventorTeaching

Languages English

From Milad's professional profile.

Deals · 1

Revalia Bio, Inc.Board seat

via Entrepreneur First · filed Nov 2024 · $17M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Pamir Ventures

Anand Subramanian

General Partner at Pamir Ventures

Network4

Alice BentinckScout

Cofounder and CEO at Entrepreneur First

Alice ZhangScout

Angel

Barney PellScout

Venture Partner at Radical Ventures

Eros ResminiScout

Managing Partner at The Mini Fund

Investors connected to Milad in public investor directories — a warm-intro map.

Frequently asked questions

Who is Milad Alucozai?: Milad Alucozai, a former bench scientist turned founder (Mekonos, Corstem, Revalia Bio), brings deep technical and operator expertise, mentors at Wyss Institute, and co‑launched Code to Cure on AI–biology convergence.
Where does Milad Alucozai work?: Milad Alucozai is Co-Founder & General Partner at Pamir Ventures and Co-Founder at Revalia Bio, Inc..
What does Milad Alucozai invest in?: Milad Alucozai invests in AgTech, AI & Machine Learning, Biotech, Climate Tech, Deep Tech, FoodTech, Hardware.
What check size does Milad Alucozai write?: Milad Alucozai typically writes checks of $500K.
What boards does Milad Alucozai sit on?: Milad Alucozai holds tracked board seats at Revalia Bio, Inc..
Where did Milad Alucozai go to school?: Milad Alucozai studied at Harvard University (Visiting Fellow/Scholar, Wyss Institute for Biologically Inspired Engineering); Purdue University (RCHE/Bindley Entrepreneurship Fellow, Healthcare Engineering); The Johns Hopkins University School of Medicine (Gordon and Marilyn Macklin Fellow).